David V Glidden
Overview
Explore the profile of David V Glidden including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
235
Citations
11008
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodriguez Almaraz E, Guerra G, Al-Adli N, Young J, Dada A, Quintana D, et al.
Neurooncol Adv
. 2025 Mar;
7(1):vdaf024.
PMID: 40051658
Background: Isocitrate dehydrogenase (IDH)-mutant astrocytomas represent the most frequent primary intraparenchymal brain tumor in young adults, which typically arise as low-grade neoplasms that often progress and transform to higher grade...
2.
Spinelli M, Heise M, Gistand N, Cox C, Grochowski J, Oskarsson J, et al.
JAMA
. 2025 Mar;
PMID: 40048173
No abstract available.
3.
Sankaran M, Glidden D, Kohn R, Nguyen T, Bacon O, Buchbinder S, et al.
JAMA Intern Med
. 2025 Jan;
185(3):266-272.
PMID: 39761052
Importance: Increasing rates of sexually transmitted infections (STIs) have been associated with rises in serious morbidity. While doxycycline postexposure prophylaxis (doxyPEP), a strategy in which individuals take doxycycline, 200 mg,...
4.
Crook S, Rosenbluth G, Glidden D, Fernandez A, Lee C, Avina L, et al.
J Am Med Inform Assoc
. 2024 Dec;
32(3):572-578.
PMID: 39688734
Objectives: We sought to assess whether race, ethnicity, and preferred language were associated with digital health literacy in pediatric caregivers. Materials And Methods: We used linear regression to measure associations...
5.
Bhimraj A, Falck-Ytter Y, Kim A, Li J, Baden L, Johnson S, et al.
Clin Infect Dis
. 2024 Oct;
PMID: 39471458
This article provides a focused update to the clinical practice guideline on the treatment and management of patients with coronavirus disease 2019, developed by the Infectious Diseases Society of America....
6.
Schaefer R, Donaldson L, Leus M, Osakwe C, Chimukangara B, Dalal S, et al.
PLOS Glob Public Health
. 2024 Oct;
4(10):e0003878.
PMID: 39446892
No abstract available.
7.
Byakwaga H, Semeere A, Laker-Oketta M, Busakhala N, Freeman E, Rotich E, et al.
medRxiv
. 2024 Sep;
PMID: 39252899
Background: Despite widespread access to antiretroviral therapy (ART) in the "Treat All" era, HIV-associated Kaposi sarcoma (KS) remains among the most common malignancies in sub-Saharan Africa. Survival after KS diagnosis...
8.
Jain J, Heise M, Lisha N, Moreira C, Glidden D, Burkholder G, et al.
Open Forum Infect Dis
. 2024 Sep;
11(9):ofae491.
PMID: 39252870
Background: Rising overdose deaths globally and increased social isolation during the coronavirus disease 2019 (COVID-19) pandemic may have disproportionately impacted people with human immunodeficiency virus (PWH) with substance use disorders...
9.
Koss C, Gandhi M, Halvas E, Okochi H, Chu C, Glidden D, et al.
Open Forum Infect Dis
. 2024 Sep;
11(9):ofae468.
PMID: 39229286
Background: Long-acting cabotegravir (CAB-LA) is highly effective for HIV prevention, but delayed HIV diagnoses and integrase strand transfer inhibitor (INSTI) resistance were observed in trials. We report the first case...
10.
Lu S, Peluso M, Glidden D, Davidson M, Lugtu K, Pineda-Ramirez J, et al.
Nat Commun
. 2024 Aug;
15(1):7466.
PMID: 39198441
To understand the roles of acute-phase viral dynamics and host immune responses in post-acute sequelae of SARS-CoV-2 infection (PASC), we enrolled 136 participants within 5 days of their first positive...